secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001104659-24-050567
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics sets 2024 annual meeting for June 13, 2024
-----------------------------------------------------------------

- 2024 annual meeting scheduled for June 13, 2024; record date is April 22, 2024.
- Stockholder proposals for proxy inclusion must be received by April 25, 2024.
- Director nominations and other business notices also due by April 25, 2024.
- Meeting date is more than 30 days after one-year anniversary of 2023 meeting (May 10, 2023).
- Deadlines set under Exchange Act Rule 14a-5(f) and Rule 14a-8.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924050567/0001104659-24-050567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924050567/tm2411028d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-050567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer